← All Sponsors
SPONSOR

OncoVerity, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Leukemia, Myeloid, Acute
NCT06384261 Phase 2
Recruiting

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

Leukemia, Myeloid, Acute
United States, Canada, Germany View Trial →